Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
October 2002
Author

Publication date
01-10-2002
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2002
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-002-0849-3

Other articles of this Issue 10/2002

European Journal of Clinical Microbiology & Infectious Diseases 10/2002 Go to the issue

Concise Article

A Case of Infant Botulism due to Neurotoxigenic Clostridium butyricum Type E Associated with Clostridium difficile Colitis

Concise Article

Oro-Dental Bacteria in Various Atherosclerotic Arteries

Current Topic: Article

Designation of the European Working Group on Legionella Infection (EWGLI) Amplified Fragment Length Polymorphism Types of Legionella pneumophila Serogroup 1 and Results of Intercentre Proficiency Testing Using a Standard Protocol

Current Topic: Article

Residential Water Supply as a Likely Cause of Community-Acquired Legionnaires' Disease in an Immunocompromised Host

Brief Report

Drug Resistance in Pulmonary Tuberculosis in Istanbul

Brief Report

Clinical Significance of Herpes Simplex Virus in the Lower Respiratory Tract of Critically Ill Patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits